NEW YORK (GenomeWeb) – Started as a company to monitor a person’s smoking habit, UK firm GFC Diagnostics is developing a medical device to detect antibiotic-resistance biomarkers in bacteria that it said can provide results significantly quicker than current technologies being used.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.